These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8506418)

  • 1. Immunohistochemistry in the evaluation of melanocytic tumors.
    Ruiter DJ; Bröcker EB
    Semin Diagn Pathol; 1993 Feb; 10(1):76-91. PubMed ID: 8506418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reactivity of five different antibodies with benign and malignant melanocytic lesions].
    Plótár V; Szentirmay Z; Orosz Z
    Magy Onkol; 2008 Dec; 52(4):363-73. PubMed ID: 19068464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical aid at risk stratification of melanocytic neoplasms.
    Quatresooz P; Arrese JE; Pierard-Franchimont C; Pierard GE
    Int J Oncol; 2004 Jan; 24(1):211-6. PubMed ID: 14654959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KBA.62: a useful marker for primary and metastatic melanomas.
    Pagès C; Rochaix P; al Saati T; Valmary-Degano S; Boulinguez S; Launay F; Carle P; Lauwers F; Payoux P; Le Guellec S; Brousset P; Lamant L
    Hum Pathol; 2008 Aug; 39(8):1136-42. PubMed ID: 18495211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical characteristics of melanoma.
    Ohsie SJ; Sarantopoulos GP; Cochran AJ; Binder SW
    J Cutan Pathol; 2008 May; 35(5):433-44. PubMed ID: 18399807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in molecular staging of melanoma patients: multimarker analysis of archival lymph node tissue.
    Busam KJ
    J Clin Oncol; 2003 Oct; 21(19):3550-1. PubMed ID: 12913105
    [No Abstract]   [Full Text] [Related]  

  • 8. [Monoclonal antibody HMB-45 in diagnosis of intra-ocular melanoma].
    Rohrbach JM; Steuhl KP; Thanos S
    Klin Monbl Augenheilkd; 1991 Oct; 199(4):274-7. PubMed ID: 1762354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standard immunostains for melanoma in sentinel lymph node specimens: which ones are most useful?
    Karimipour DJ; Lowe L; Su L; Hamilton T; Sondak V; Johnson TM; Fullen D
    J Am Acad Dermatol; 2004 May; 50(5):759-64. PubMed ID: 15097961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immuno-diagnosis of malignant melanoma].
    Szekeres G; Battyáni Z
    Magy Onkol; 2003; 47(1):45-50. PubMed ID: 12704454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of HLA-Dr and CD1+ cells in malignant and benign pigmentary tumors].
    Ramírez-Bosca A; Valcuende-Cavero F; Rufat-Pérez MJ; Castells-Rodellas A
    Med Cutan Ibero Lat Am; 1989; 17(1):58-64. PubMed ID: 2474114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas.
    Yu CH; Chen HH; Liu CM; Jeng YM; Wang JT; Wang YP; Liu BY; Sun A; Chiang CP
    J Oral Pathol Med; 2005 Oct; 34(9):540-5. PubMed ID: 16138892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoconjugate profiling of primary melanoma and its sentinel node and distant metastases: implications for diagnosis and pathophysiology of metastases.
    Thies A; Berlin A; Brunner G; Schulze HJ; Moll I; Pfüller U; Wagener C; Schachner M; Altevogt P; Schumacher U
    Cancer Lett; 2007 Apr; 248(1):68-80. PubMed ID: 16822608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical evaluation of necrotic malignant melanomas.
    Nonaka D; Laser J; Tucker R; Melamed J
    Am J Clin Pathol; 2007 May; 127(5):787-91. PubMed ID: 17439838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
    Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
    Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma associated differentiation antigens: investigation with monoclonal antibodies.
    Carrel S; Schreyer M; Giuffrè L
    Prog Clin Biol Res; 1988; 256():585-95. PubMed ID: 3130642
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunophenotype analysis of dendritic cells and lymphocytes associated with cutaneous malignant melanomas.
    García-Plata D; Lessana-Leibowitch M; Palangie A; Gulliemette J; Sedel D; Méndez L; Mozos E
    Invasion Metastasis; 1995; 15(3-4):125-34. PubMed ID: 8621268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor antigen expression in melanoma varies according to antigen and stage.
    Barrow C; Browning J; MacGregor D; Davis ID; Sturrock S; Jungbluth AA; Cebon J
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):764-71. PubMed ID: 16467087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemistry in melanocytic proliferative lesions.
    de Wit NJ; van Muijen GN; Ruiter DJ
    Histopathology; 2004 Jun; 44(6):517-41. PubMed ID: 15186267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of immunohistochemical markers in the diagnosis of carcinoma of the breast].
    Bussolati G
    Minerva Chir; 1988 Sep; 43(18 Suppl):5-7. PubMed ID: 3226595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.